INTERCALATION WITH DNA IS A PREREQUISITE FOR DAUNOMYCIN, ADRIAMYCIN AND ITS CONGENERS IN INHIBITING DNAASE I.FACCHINETTI T; MANTOVANI A; CANTONI L et al.1978; CHEMICO-BIOL. INTERACTIONS; NETHERL.; DA. 1978; VOL. 20; NO 1; PP. 97-102; BIBL. 10 REF.Article

INTERACTION OF ADRIAMYCIN IN VITRO WITH CARDIAC MYOFIBRILLAR PROTEINSLEWIS W; KLEINERMAN J; PUSZKIN S et al.1982; CIRC. RES.; ISSN 0009-7330; USA; DA. 1982; VOL. 50; NO 4; PP. 547-553; BIBL. 23 REF.Article

ADRIAMYCIN INDUCED IMMUNOMODULATION: DEPENDENCE UPON TIME OF ADMINISTRATIONEHRKE MJ; TOMAZIC V; RYOYAMA K et al.1983; INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY; ISSN 0192-0561; USA; DA. 1983; VOL. 5; NO 1; PP. 43-48; BIBL. 23 REF.Article

N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE, AN ANALOG WITH GREATER EXPERIMENTAL ANTITUMOR ACTIVITY AND LESS TOXICITY THAN ADRIAMYCIN = LE VALERATE-14 DE N-TRIFLUOROACETYLADRIAMYCINE, UN ANALOGUE AVEC UNE PLUS GRANDE ACTIVITE ANTITUMORALE EXPERIMENTALE ET UNE TOXICITE MOINDRE QUE L'ADRIAMYCINEISRAEL M; MODEST EJ; FREI E III et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 5; PP. 1365-1368; BIBL. 25REF.Article

INHIBITION OF DRUG OXIDATION AND STIMULATION OF NADPH OXIDASE IN VITRO BY DOXORUBICIN AND TRIFERRIC-DOXORUBICINVAN BOXTEL CJ; CHRASTIL J; WILSON JT et al.1979; PHARMACOLOGY; CHE; DA. 1979; VOL. 19; NO 1; PP. 5-11; BIBL. 14 REF.Article

A "HEXOKINASE EFFECT" IN THE INHIBITION OF OXIDATIVE PHOSPHORYLATION IN HEART MUSCLE MITOCHONDRIA BY ADRIAMYCINMUHAMMED H; RAMASARMA T; RAMAKRISHNA KURUP CK et al.1982; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1982; VOL. 105; NO 4; PP. 1440-1445; BIBL. 15 REF.Article

CHEMOTHERAPEUTIC STUDY ON YOSHIDA SARCOMA ASCITES CELLS IMPLANTED INTO THE GLANDULAR STOMACH OF RATS: MONOTHERAPY WITH 5-FLUOROURACIL, METHYL-CCNU, MITOMYCIN C, ADRIAMYCIN, AND CYTOSINE ARABINOSIDE, AND COMBINATION THERAPY WITH RESPECTIVE TWO-DRUG COMBINATIONSEICHLER G; HABS M; SCHMAEHL D et al.1983; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1983; VOL. 105; NO 3; PP. 250-257; BIBL. 21 REF.Article

HYPERTHERMIC POTENTIATION OF DOXORUBICIN AND 4'-EPIDOXORUBICIN IN A TRANSPLANTABLE NEUROGENIC RAT TUMOR (BT₄A) IN BD IX RATS = POTENTIALISATION PAR HYPERTHERMIE DE LA DOXORUBICINE ET DE LA 4'-EPI-DOXORUBICINE DANS UNE TUMEUR NEUROGENE TRANSPLANTABLE DU RAT (BT₄A) CHEZ DES RATS BD IXDAHL O.1983; INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS; ISSN 0360-3016; USA; DA. 1983; VOL. 9; NO 2; PP. 203-207; ABS. ENG; BIBL. 30 REF.; GRAPHArticle

CHEMOTHERAPY OF HUMAN COLORECTAL TUMOR XENOGRAFTS IN ATHYMIC MICE WITH CLINICALLY ACTIVE DRUGS: 5-FLUOROURACILE AND 1-3 BIS-(-2CHLOROETHYL 1)-1-NITROSOUREA (BCNU). COMPARISON WITH DOXORUBICIN DERIVATIVE: 4' DEOXYDOXORUBICIN AND 4'-O-METHYLDOXORUBICINGIULIANI FC; ZIRVI KA; KAPLAN NO et al.1981; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1981; VOL. 27; NO 1; PP. 5-13; BIBL. 49 REF.Article

ULTRASTRUCTURAL STUDY OF THE CARDIOTOXICITY AND LIGHT-MICROSCOPIC FINDINGS OF THE SKIN AFTER TREATMENT OF GOLDEN HAMSTERS WITH SEVEN DIFFERENT ANTHRACYCLINESDANTCHEV D; SLIOUSSARTCHOUK V; PAINTRAND M et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 74; PP. 223-249; BIBL. 12 REF.Article

SYNTHESIS OF ADRIAMYCIN - COUPLED POLYGLUTARALDEHYDE MICROSPHERES AND EVALUATION OF THEIR CYTOSTATIC ACTIVITYTOKES ZA; ROGERS KE; REMBAUM A et al.1982; PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. BIOLOGICAL SCIENCES; ISSN 0273-1134; USA; DA. 1982; VOL. 79; NO 6; PP. 2026-2030; BIBL. 16 REF.Article

ADRIAMYCIN-ACTIVATED MACROPHAGES AS TUMOR GROWTH INHIBITORSHASKILL JS.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 10; PP. 3852-3856; BIBL. 16 REF.Article

DNA COMPLEXES OF DAUNORUBICIN (NSC-82151) AND ADRIAMYCINTROUET A; DE DUVE C.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 260; BIBL. 2REF.Article

ANTITUMOR ACTIVITY IN MICE OF 4'-DEOXYDOXORUBICIN IN COMPARISON WITH DOXORUBICIN = ACTIVITE ANTITUMORALE CHEZ LA SOURIS DE LA 4'-DESOXYDOXORUBICINE COMPAREE A CELLE DE LA DOXORUBICINECASAZZA AM; SAVI G; PRATESI G et al.1983; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1983; VOL. 19; NO 3; PP. 411-418; ABS. ENG; BIBL. 17 REF.; GRAPHArticle

IN VITRO RESPONSES OF NUDE MOUSE-XENOGRAFTED HUMAN COLON CARCINOMAS EXPOSED TO DOXORUBICIN DERIVATIVES IN TISSUE CULTURE AND IN THE MOUSEZIRVI KA; VAN DER BOSCH J; KAPLAN NO et al.1982; CANCER RES.; USA; DA. 1982; VOL. 42; NO 9; PP. 3793-3797; BIBL. 12 REF.Article

FLUORESCENCE ASSAYS AND PHARMACOKINETIC STUDIES OF 4'-DEOXYDOXORUBICIN AND DOXORUBICIN IN ORGANS OF MICE BEARING SOLID TUMORSFORMELLI F; POLLINI C; CASAZZA AM et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 5; NO 3; PP. 139-144; BIBL. 11 REF.Article

INHIBITION OF CARDIAC GUANYLATE CYCLASE BY DOXORUBICIN AND SOME OF ITS ANALOGS: POSSIBLE RELATIONSHIP TO CARDIOTOXICITYLEHOTAY DC; LEVEY BA; ROGERSON BJ et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 2; PP. 311-316; BIBL. 43 REF.Article

INHIBITION OF CHICKEN MYELOBLASTOSIS RNA POLYMERASE II ACTIVITY IN VITRO BY N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATECHUANG LF; KAWAHATA RT; CHUANG RY et al.1980; F.E.B.S. LETTERS; NLD; DA. 1980; VOL. 117; NO 1; PP. 247-251; BIBL. 16 REF.Article

STUDIES ON THE COMPARATIVE DISTRIBUTION AND BILIARY EXCRETION OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN MICE AND RATSBROGGINI M; COLOMBO T; MARTINI A et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 8-9; PP. 897-904; BIBL. 26 REF.Article

EFFECT OF DAUNOMYCIN, ADRIAMYCIN AND ITS CONGENER AD 32 ON THE ACTIVITY OF DNASE I FROM BOVINE PANCREAS.FACCHINETTI T; MANTOVANI A; CANTONI R et al.1977; BIOCHEM. PHARMACOL.; G.B.; DA. 1977; VOL. 26; NO 20; PP. 1953-1954; BIBL. 21 REF.Article

Early detection of doxorubicin-induced myocardial damage by ultrasound tissue characterization with integrated backscatterYOKOYAMA, Naoyuki; TAKESHITA, Satoshi; KOZUMA, Ken et al.Circulation journal. 2003, Vol 67, Num 11, pp 929-933, issn 1346-9843, 5 p.Article

Fabrication of double-walled microspheres for the sustained release of doxorubicinENG CHEW TAN; RONGYI LIN; WANG, Chi-Hwa et al.Journal of colloid and interface science. 2005, Vol 291, Num 1, pp 135-143, issn 0021-9797, 9 p.Article

Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity : Translational ProteomicsGRATIA, Séverine; KAY, Laurence; MICHELLAND, Sylvie et al.Journal of proteomics (Print). 2012, Vol 75, Num 15, pp 4705-4716, issn 1874-3919, 12 p.Article

COMPARATIVE TOXICITY OF ADRIAMYCIN AND ADRIAMYCIN-DNA IN RATSGIROUX L; SMEESTERS C; BOURY F et al.1983; REVUE CANADIENNE DE BIOLOGIE EXPERIMENTALE; ISSN 512257; CAN; DA. 1983; VOL. 42; NO 1; PP. 67-72; ABS. FRE; BIBL. 13 REF.Article

ATTIVITA ANTIMICOPLASMATICA DI DUE ANTIBIOTICI ANTRACICLINICI = ACTIVITE ANTIMYCOPLASME DE DEUX ANTIBIOTIQUES DERIVES DE L'ANTRACYCLINEBUOGO A; ZANUSO G.1975; BOLL. IST. SIEROTERAP. MILAN.; ITAL.; DA. 1975; VOL. 34; NO 5; PP. 378-381; ABS. ANGL.; BIBL. 4 REF.Article